BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20576349)

  • 1. All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK.
    Futami H; Sakai R
    Cancer Lett; 2010 Nov; 297(2):220-5. PubMed ID: 20576349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
    Passoni L; Longo L; Collini P; Coluccia AM; Bozzi F; Podda M; Gregorio A; Gambini C; Garaventa A; Pistoia V; Del Grosso F; Tonini GP; Cheng M; Gambacorti-Passerini C; Anichini A; Fossati-Bellani F; Di Nicola M; Luksch R
    Cancer Res; 2009 Sep; 69(18):7338-46. PubMed ID: 19723661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.
    Schönherr C; Yang HL; Vigny M; Palmer RH; Hallberg B
    Oncogene; 2010 May; 29(19):2817-30. PubMed ID: 20190816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic mutations of ALK kinase in neuroblastoma.
    Chen Y; Takita J; Choi YL; Kato M; Ohira M; Sanada M; Wang L; Soda M; Kikuchi A; Igarashi T; Nakagawara A; Hayashi Y; Mano H; Ogawa S
    Nature; 2008 Oct; 455(7215):971-4. PubMed ID: 18923524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological role of anaplastic lymphoma kinase in neuroblastoma.
    Osajima-Hakomori Y; Miyake I; Ohira M; Nakagawara A; Nakagawa A; Sakai R
    Am J Pathol; 2005 Jul; 167(1):213-22. PubMed ID: 15972965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos.
    Merrill RA; Ahrens JM; Kaiser ME; Federhart KS; Poon VY; Clagett-Dame M
    Biol Chem; 2004 Jul; 385(7):605-14. PubMed ID: 15318809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy.
    Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schönherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
    Cancer Res; 2011 Jan; 71(1):98-105. PubMed ID: 21059859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
    Wittrock J; Schweizer P; Girgert R
    Anticancer Res; 2002; 22(6C):4205-9. PubMed ID: 12553057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.
    Niizuma H; Nakamura Y; Ozaki T; Nakanishi H; Ohira M; Isogai E; Kageyama H; Imaizumi M; Nakagawara A
    Oncogene; 2006 Aug; 25(36):5046-55. PubMed ID: 16568081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cells.
    Shen JH; Zhang Y; Wu NH; Shen YF
    Neurosci Lett; 2007 Mar; 414(2):110-4. PubMed ID: 17293044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells.
    Yanaka N; Nogusa Y; Fujioka Y; Yamashita Y; Kato N
    FEBS Lett; 2007 Feb; 581(4):712-8. PubMed ID: 17275818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.